Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Brown University
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Boehringer Ingelheim
Revolution Medicines, Inc.
Mayo Clinic
Brigham and Women's Hospital
Swiss Cancer Institute
Intergroupe Francophone de Cancerologie Thoracique
Tongji Hospital
BeiGene
Arcus Biosciences, Inc.
Incyte Corporation
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Azienda USL Reggio Emilia - IRCCS
Bank of Cyprus Oncology Centre
Ohio State University Comprehensive Cancer Center
NanOlogy, LLC
SWOG Cancer Research Network
Instituto Nacional de Cancerologia de Mexico
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Memorial Sloan Kettering Cancer Center
Alethia Biotherapeutics
Vergent Bioscience, Inc.
Spanish Lung Cancer Group
University of Texas Southwestern Medical Center
Optimal Health Research
EpicentRx, Inc.
Latin American Cooperative Oncology Group
University of Pittsburgh
OncoNano Medicine, Inc.
University of Rochester
BeiGene
AstraZeneca
Vergent Bioscience, Inc.
Sun Yat-sen University
Celgene
Case Comprehensive Cancer Center
SWOG Cancer Research Network
SWOG Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)